With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
As COVID-19 preparedness enters a new phase, NACDS urges continuity of policies enabling pharmacies to provide key services patients expect and need.
On Tuesday, the National Association of Chain Drug Stores (NACDS) and 93 other patient, public health, and state and national pharmacy groups signed a letter to the Biden Administration urging “formal clarification from the U.S. Department of Health and Human Services (HHS) on potential expiration of pharmacy personnel flexibilities granted during the pandemic.”
Plan reflects NACDS’ comments from 2019 as well as lessons and recommendations from the COVID-19 pandemic.
NACDS urges Biden Administration to ensure clarity or to act decisively to extend PREP Act authorities that have served Americans well, and that Americans do not want to see rolled back.
The third in a series of reports shows how valuable experiences and lessons learned during the COVID pandemic response can help inform policy decisions and future pandemic planning and preparedness.
Appreciates the recognition of pharmacies’ need to plan ahead to be ready should the FDA and CDC authorize COVID shots for this age group.
